[go: up one dir, main page]

Miao et al., 2018 - Google Patents

Surface-bioengineered gold nanoparticles for biomedical applications

Miao et al., 2018

View PDF
Document ID
6725276531335241648
Author
Miao Z
Gao Z
Chen R
Yu X
Su Z
Wei G
Publication year
Publication venue
Current Medicinal Chemistry

External Links

Snippet

The conjugation of gold nanoparticles (AuNPs) with biomolecules could create many outstanding biofunctions for the surface-functionalized nanoparticles and extend their biomedical applications. In this review, we summarize the recent advances in the surface …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A61K47/48884—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A61K47/48892—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb

Similar Documents

Publication Publication Date Title
Miao et al. Surface-bioengineered gold nanoparticles for biomedical applications
Lee et al. Simultaneous stabilization and functionalization of gold nanoparticles via biomolecule conjugation: progress and perspectives
Nejati et al. Biomedical applications of functionalized gold nanoparticles: a review
Amina et al. A review on the synthesis and functionalization of gold nanoparticles as a drug delivery vehicle
Li et al. AuNPs as an important inorganic nanoparticle applied in drug carrier systems
Abbasi Kajani et al. Recent advances in nanomaterials development for nanomedicine and cancer
Borzenkov et al. Thermal and chemical stability of thiol bonding on gold nanostars
Xia et al. Quantifying the coverage density of poly (ethylene glycol) chains on the surface of gold nanostructures
Kumar et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging
Wu et al. Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy
Schneider et al. Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy
Ravindran et al. Biofunctionalized silver nanoparticles: advances and prospects
Zeng et al. Multifunctional surface modification of nanodiamonds based on dopamine polymerization
Tauran et al. Molecular recognition by gold, silver and copper nanoparticles
Tiwari et al. Functionalized gold nanoparticles and their biomedical applications
Guerrero et al. Gold nanoparticles for photothermally controlled drug release
Zhang et al. Multifunctional gold nanoparticle-based fluorescence resonance energy-transfer probe for target drug delivery and cell fluorescence imaging
Ma et al. Applications of gold nanorods in biomedical imaging and related fields
Zhang et al. pH-controlled intracellular in situ reversible assembly of a photothermal agent for smart chemo-photothermal synergetic therapy and ATP imaging
Sharma et al. Gold nanoparticles synthesis, properties, and forthcoming applications-a review
Raghvendra et al. Diagnostics and therapeutic application of gold nanoparticles
Mohammed et al. Gold Nanoparticle: Synthesis, Functionalization, Enhancement, Drug Delivery and Therapy: A Review.
Choi et al. Smart nanomaterials for biomedics
Zhang et al. Noble metal nanoparticles: Synthesis, and biomedical implementations
Wang et al. Self-decomposable mesoporous doxorubicin@ silica nanocomposites for nuclear targeted chemo-photodynamic combination therapy